Medtronic MDT Medical Surgical — Research and development expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medtronic's medical surgical — research and development expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medtronic's medical surgical — research and development expense?
- Medtronic (MDT) reported medical surgical — research and development expense of $163M in Q1 2026.
- How has Medtronic's medical surgical — research and development expense changed year-over-year?
- Medtronic's medical surgical — research and development expense decreased by 3.6% year-over-year, from $169M to $163M.
- What is the long-term trend for Medtronic's medical surgical — research and development expense?
- Over 3 years (2023 to 2026), Medtronic's medical surgical — research and development expense has grown at a 8.2% compound annual growth rate (CAGR), from $543M to $687M.
- What does medical surgical — research and development expense mean?
- The amount spent on researching and developing new products within the Medical Surgical business unit.
- How do you interpret medical surgical — research and development expense?
- Higher spending indicates a focus on future growth and innovation, while lower spending may signal cost-cutting or a mature product cycle.
- How does medical surgical — research and development expense compare across companies?
- Standard R&D expense reported by medical device peers like Stryker or Boston Scientific.